Cancer Vaccines
"Tumor Vaccines Containing Reconstituted Tumor Membranes."
Published in Medical Letter on the CDC and FDA, April 12th, 1999
NIH Grant Number: IR55CA72474-01A1. Grant Expires: September 14, 1999. Principle Investigator: Peter E. Jensen. Performing Organization: Emory University, Atlanta, Georgia. Description: Considerable effort has recently been focused on increasing the immunogenicity of tumors by using gene transfer techniques with the goal of developing useful cellular vaccines for treatment of Cancer. Promising results have been obtained in experimental models in which tumors are engineered to express genes encoding cytokines, costimulatory molecules such as B7, or MHC proteins. However, a number of technical problems may limit the practical utilization of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Diagnosis
PCR Testing of Aspirates Doesn't Spot TB in Children - Gallbladder Disease (Risk Factors)
Weight Maintenance Essential To Avoid Surgery - Immunization
Combined Flu/HBV Vaccine Effective in Alaskan Study - Prevention
Hepatitis and Alcohol are One-Two Punch for Liver Disease - Heart Disease (Risk Factors)
Motherhood Tied to Less Physical Activity - Infant Mortality
Infant Mortality Declines Among Northwest American Indians and Alaska Natives - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
